title: Low-dose folic acid supplementation does not influence plasma methionine concentrations in young non-pregnant women.
abstract: An elevated plasma total homocysteine (tHcy) concentration is a risk factor for cardiovascular disease and for having offspring with a neural-tube defect. Folate is a methyl donor in the remethylation of homocysteine into methionine. Although folic acid supplementation decreases tHcy concentrations, effects of folic acid supplementation on plasma methionine concentrations are unclear. There is also concern that folic acid supplementation negatively affects vitamin B12 status. We studied effects of low-dose folic acid supplementation on methionine and vitamin B12 concentrations in plasma. We also investigated whether baseline plasma methionine and tHcy concentrations correlated with the baseline folate and vitamin B12 status. For a period of 4 weeks, 144 young women received either 500 micrograms folic acid each day, or 500 micrograms folic acid and placebo tablets on alternate days, or a placebo tablet each day. Plasma methionine, tHcy and plasma vitamin B12 concentrations were measured at start and end of the intervention period. Folic acid supplementation had no effect on plasma methionine or plasma vitamin B12 concentrations although it significantly decreased tHcy concentrations. Plasma methionine concentrations showed no correlation with either tHcy concentrations (Spearman rs-0.01, P = 0.89), or any of the blood vitamin variables at baseline. Baseline tHcy concentrations showed a slight inverse correlation with baseline concentrations of plasma vitamin B12 (rs-0.25, P < 0.001), plasma folate (rs-0.24, P < 0.01) and erythrocyte folate (rs-0.19, P < 0.05). In conclusion, low-dose folic acid supplementation did not influence plasma methionine or plasma vitamin B12 concentrations. Furthermore, no correlation between plasma methionine concentrations and the blood folate and vitamin B12 status was shown.
authors.affiliation: Division of Human Nutrition and Epidemiology, Wageningen Agricultural University, The Netherlands. ingeborg.brouwer@staff.NutEpi.wau.nl
authors.forename: I A
authors.initials: IA
authors.lastname: Brouwer
authors.forename: M
authors.initials: M
authors.lastname: van Dusseldorp
authors.forename: M
authors.initials: M
authors.lastname: Duran
authors.forename: C M
authors.initials: CM
authors.lastname: Thomas
authors.forename: J G
authors.initials: JG
authors.lastname: Hautvast
authors.forename: T K
authors.initials: TK
authors.lastname: Eskes
authors.forename: R P
authors.initials: RP
authors.lastname: Steegers-Theunissen
mesh_terms: D000293:Adolescent; D000328:Adult; D003276:Contraceptives, Oral / Q000008:administration & dosage; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage* / Q000378:metabolism; D006710:Homocysteine / Q000097:blood; D006801:Humans; D020138:Hyperhomocysteinemia / Q000188:drug therapy; D008715:Methionine / Q000097:blood*; D014805:Vitamin B 12 / Q000097:blood
chemical_list: D003276:Contraceptives, Oral; D006710:Homocysteine; D005492:Folic Acid; D008715:Methionine; D014805:Vitamin B 12